| Authors: |
Torres F; Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, HCI F217, Eidgenossische Technische Hochschule Zurich, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland., Walser R; BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB4 0WG, United Kingdom., Kaderli J; Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, HCI F217, Eidgenossische Technische Hochschule Zurich, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland., Rossi E; Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, HCI F217, Eidgenossische Technische Hochschule Zurich, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland., Bobby R; BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB4 0WG, United Kingdom., Packer MJ; Oncology R&D, AstraZeneca, Cambridge, CB4 0WG, United Kingdom., Sarda S; BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB4 0WG, United Kingdom., Walker G; Drug Discovery Unit, Cancer Research UK Manchester Institute, Alderley Park, Macclesfield SK10 4TG, United Kingdom., Hitchin JR; Drug Discovery Unit, Cancer Research UK Manchester Institute, Alderley Park, Macclesfield SK10 4TG, United Kingdom., Milbradt AG; BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB4 0WG, United Kingdom., Orts J; Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, HCI F217, Eidgenossische Technische Hochschule Zurich, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland.; Department of Pharmaceutical Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria. |